Articles

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of...

Bonnie H. Weiner

The Accreditation for Cardiovascular Excellence (ACE) is the exclusive international provider of interventional cardiology, electrophysiology, congenital heart disease and endovascular...

corpath, corindus, cath lab robot, robotics PCI

Long-term exposure to ionizing radiation is a primary occupational concern for today's interventional cardiologists. To address these concerns, many interventional cardiologists are enlisting the...

IABP, peer review, Maquet, Journal of Invasive Cardiology

Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps (IABPs) versus...

electronic stents, bioresorbable electronic stent, BES

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion...

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock

Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset...

ART, PBS, pure bioresorbable scaffold, CE Mark

Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its next-generation drug-free, pure bioresorbable scaffold used to treat coronary artery disease. The...

CT-FFR, Heartflow Analysis, coronary artery disease, EuroPCR, RIPCORD

Adding the HeartFlow FFRCT Analysis to a standard coronary computed tomography angiogram (cCTA) may change the course of treatment in more than one-third of patients with...

Edwards, Fortis, transcatheter mitral valve, trial, halts enrollment

Edwards Lifesciences announced it has temporarily halted its clinical trial of the Fortis mitral transcatheter heart valve. The company said that in consultation with trial investigators, it was...

antiplatelet medication, prasugrel, clopidogrel, risk algorithm, SCAI

A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients who stand to benefit from intensive...